133 related articles for article (PubMed ID: 11427947)
1. Use of odds ratio or relative risk to measure a treatment effect in clinical trials with multiple correlated binary outcomes: data from the NINDS t-PA stroke trial.
Lu M; Tilley BC;
Stat Med; 2001 Jul; 20(13):1891-901. PubMed ID: 11427947
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the risk difference, risk ratio and odds ratio scales for quantifying the unadjusted intervention effect in cluster randomized trials.
Ukoumunne OC; Forbes AB; Carlin JB; Gulliford MC
Stat Med; 2008 Nov; 27(25):5143-55. PubMed ID: 18613226
[TBL] [Abstract][Full Text] [Related]
3. Methods and processes for the reanalysis of the NINDS tissue plasminogen activator for acute ischemic stroke treatment trial.
Hertzberg V; Ingall T; O'Fallon W; Asplund K; Goldfrank L; Louis T; Christianson T
Clin Trials; 2008; 5(4):308-15. PubMed ID: 18697845
[TBL] [Abstract][Full Text] [Related]
4. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
5. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting power of tests for multiple binary outcomes.
Mascha EJ; Imrey PB
Stat Med; 2010 Dec; 29(28):2890-904. PubMed ID: 20862669
[TBL] [Abstract][Full Text] [Related]
7. Adjusted intraclass correlation coefficients for binary data: methods and estimates from a cluster-randomized trial in primary care.
Yelland LN; Salter AB; Ryan P; Laurence CO
Clin Trials; 2011 Feb; 8(1):48-58. PubMed ID: 21335589
[TBL] [Abstract][Full Text] [Related]
8. A simulation study of odds ratio estimation for binary outcomes from cluster randomized trials.
Ukoumunne OC; Carlin JB; Gulliford MC
Stat Med; 2007 Aug; 26(18):3415-28. PubMed ID: 17154246
[TBL] [Abstract][Full Text] [Related]
9. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
10. [Alteplase treatment for acute stroke 2007: an effective therapeutic option at our disposal].
Carneado-Ruiz J; Saver JL
Rev Neurol; 2007 Jul 1-15; 45(1):42-52. PubMed ID: 17620265
[TBL] [Abstract][Full Text] [Related]
11. A regional system of stroke care provides thrombolytic outcomes comparable with the NINDS stroke trial.
LaMonte MP; Bahouth MN; Magder LS; Alcorta RL; Bass RR; Browne BJ; Floccare DJ; Gaasch WR;
Ann Emerg Med; 2009 Sep; 54(3):319-27. PubMed ID: 19101059
[TBL] [Abstract][Full Text] [Related]
12. Emergency physician survey: recombinant tissue plasminogen activator for stroke.
Mann J
Ann Emerg Med; 2006 Oct; 48(4):476; author reply 477. PubMed ID: 16997689
[No Abstract] [Full Text] [Related]
13. Relative risks and confidence intervals were easily computed indirectly from multivariable logistic regression.
Localio AR; Margolis DJ; Berlin JA
J Clin Epidemiol; 2007 Sep; 60(9):874-82. PubMed ID: 17689803
[TBL] [Abstract][Full Text] [Related]
14. How important is surrogate consent for stroke research?
Flaherty ML; Karlawish J; Khoury JC; Kleindorfer D; Woo D; Broderick JP
Neurology; 2008 Nov; 71(20):1566-71. PubMed ID: 18753472
[TBL] [Abstract][Full Text] [Related]
15. A generalized estimating equation approach for modeling random length binary vector data.
Albert PS; Follmann DA; Barnhart HX
Biometrics; 1997 Sep; 53(3):1116-24. PubMed ID: 9290230
[TBL] [Abstract][Full Text] [Related]
16. [Prospects of thrombolytic therapy for acute ischemic stroke].
Nakashima T; Minematsu K
Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
[TBL] [Abstract][Full Text] [Related]
17. Testing the effect of treatment in experiments with correlated binary outcomes.
Zucker D; Wittes J
Biometrics; 1992 Sep; 48(3):695-709. PubMed ID: 1420835
[TBL] [Abstract][Full Text] [Related]
18. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial.
Tilley BC; Marler J; Geller NL; Lu M; Legler J; Brott T; Lyden P; Grotta J
Stroke; 1996 Nov; 27(11):2136-42. PubMed ID: 8898828
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
Localio AR; Berlin JA; Have TR
Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
[TBL] [Abstract][Full Text] [Related]
20. Percent change on the National Institutes of Health Stroke Scale: a useful acute stroke outcome measure.
Bruno A; Saha C; Williams LS
J Stroke Cerebrovasc Dis; 2009 Jan; 18(1):56-9. PubMed ID: 19110146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
